Scarica l'app Stockscreener
17.33
5.54%
0.91
Dopo l'orario di chiusura:
17.60
0.27
+1.56%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SDGR Giù?
Forum
Previsione
Precedente Chiudi:
$16.42
Aprire:
$16.68
Volume 24 ore:
1.46M
Relative Volume:
1.49
Capitalizzazione di mercato:
$1.28B
Reddito:
$193.35M
Utile/perdita netta:
$-177.58M
Rapporto P/E:
-7.0735
EPS:
-2.45
Flusso di cassa netto:
$-172.43M
1 W Prestazione:
-0.80%
1M Prestazione:
-10.62%
6M Prestazione:
-23.89%
1 anno Prestazione:
-28.80%
Intervallo 1D:
$16.65
$17.87
Intervallo di 1 settimana:
$16.07
$17.87
Portata 52W:
$15.99
$28.47
Schrodinger Inc Stock (SDGR) Company Profile
Nome
Schrodinger Inc
Settore
Industria
Telefono
503-299-1150
Indirizzo
1540 BROADWAY, NEW YORK, NY
Confronta SDGR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SDGR
Schrodinger Inc
|
17.33 | 1.21B | 193.35M | -177.58M | -172.43M | -2.45 |
|
VEEV
Veeva Systems Inc
|
225.28 | 36.12B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
68.36 | 11.62B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
40.80 | 7.50B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
86.42 | 7.23B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
39.60 | 7.08B | 11.99B | 24.18M | 234.31M | 0.2956 |
Schrodinger Inc Stock (SDGR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-15 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2025-09-30 | Iniziato | Goldman | Neutral |
| 2025-08-15 | Downgrade | Citigroup | Buy → Neutral |
| 2025-08-14 | Iniziato | Barclays | Overweight |
| 2025-07-03 | Ripresa | Morgan Stanley | Equal-Weight |
| 2024-07-02 | Iniziato | Leerink Partners | Outperform |
| 2023-12-05 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2023-05-05 | Ripresa | Piper Sandler | Overweight |
| 2022-12-19 | Iniziato | Goldman | Neutral |
| 2022-03-01 | Iniziato | Citigroup | Buy |
| 2021-11-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-19 | Iniziato | Piper Sandler | Overweight |
| 2021-11-11 | Downgrade | BofA Securities | Buy → Neutral |
| 2021-10-13 | Iniziato | Berenberg | Buy |
| 2021-09-01 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2021-05-25 | Iniziato | Craig Hallum | Buy |
| 2020-11-23 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-10-12 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-03-02 | Iniziato | BMO Capital Markets | Outperform |
| 2020-03-02 | Iniziato | Jefferies | Hold |
| 2020-03-02 | Iniziato | Morgan Stanley | Equal-Weight |
Mostra tutto
Schrodinger Inc Borsa (SDGR) Ultime notizie
Massachusetts Financial Services Co. MA Acquires 577,899 Shares of Schrodinger, Inc. $SDGR - MarketBeat
86,319 Shares in Schrodinger, Inc. $SDGR Acquired by Campbell & CO Investment Adviser LLC - MarketBeat
Stephens Investment Management Group LLC Trims Stock Holdings in Schrodinger, Inc. $SDGR - MarketBeat
Schrodinger (NASDAQ:SDGR) Shares Down 5.2%Time to Sell? - MarketBeat
Sumitomo Mitsui Trust Group Inc. Has $91.37 Million Stock Holdings in Schrodinger, Inc. $SDGR - MarketBeat
(SDGR) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Why Schrödinger Inc. stock could be next big winnerMarket Performance Report & Low Risk Entry Point Guides - Bộ Nội Vụ
Schrodinger stock rating reiterated at Buy by TD Cowen on strategic priorities By Investing.com - Investing.com South Africa
Assessing Schrödinger (SDGR) Valuation After Recent Uneven Share Price Momentum - Yahoo Finance
Schrödinger partners with Lilly TuneLab on AI drug discovery - Drug Target Review
Schrodinger stock rating reiterated at Buy by TD Cowen on strategic priorities - Investing.com Nigeria
Schrödinger Provides Update on Progress Across the Business and Outlines 2026 Strategic Priorities - BioSpace
Schrödinger outlines 2026 priorities after strong 2025 By Investing.com - Investing.com Nigeria
Schrödinger outlines 2026 priorities after strong 2025 - Investing.com
Manas AI Secures Strategic Advantage through Unique Deep Integration with Schrödinger’s Physics + AI Discovery Platform - 01net
Schrodinger, Inc. (NASDAQ:SDGR) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Chemoinformatics Market to Reach US$ 24.43 Billion by 2033 | CAGR - openPR.com
Schrodinger to offer Eli Lilly’s AI drug discovery platform on its software - WKZO
Will Schrödinger Inc. stock benefit from automation2025 Performance Recap & Capital Efficiency Focused Ideas - Улправда
Schrodinger (NASDAQ:SDGR) Rating Lowered to Sell at Wall Street Zen - MarketBeat
Schrödinger partners with Lilly TuneLab to enhance drug discovery By Investing.com - Investing.com Nigeria
Schrödinger, Inc.'s (NASDAQ:SDGR) Earnings Haven't Escaped The Attention Of Investors - 富途牛牛
Is Schrödinger’s TuneLab AI Integration Reshaping the Investment Case For SDGR? - simplywall.st
Schrödinger (SDGR) Partners with Eli Lilly for AI-Driven Drug Di - GuruFocus
Schrödinger Partners with Lilly to Make TuneLab Platform Available in LiveDesign - 01net
Schrodinger to offer Eli Lilly's AI drug discovery platform on its software - Reuters
Eli Lilly in pact with Schrödinger, Revvity for AI-driven drug discovery - MSN
Schrödinger (SDGR) Partners with Eli Lilly for AI Drug Discovery - GuruFocus
Eli Lilly in pact with Schrödinger in AI-related drug discovery - Seeking Alpha
Schrödinger partners with Lilly TuneLab to enhance drug discovery - Investing.com
Schrodinger (NASDAQ:SDGR) Upgraded to "Hold" at UBS Group - MarketBeat
Will Schrödinger Inc. stock recover faster than peersWeekly Trend Recap & Risk Managed Investment Signals - Улправда
Will Schrödinger Inc. stock beat EPS estimatesWeekly Trading Summary & Real-Time Price Movement Reports - Улправда
Is Schrödinger Inc. stock gaining market shareEarnings Recap Report & Reliable Volume Spike Alerts - Улправда
Whale Trades: Will Schrödinger Inc. stock benefit from automationQuarterly Profit Report & Accurate Buy Signal Alerts - Улправда
Schrodinger (SDGR): TD Cowen Maintains Buy Rating, Lowers Price Target | SDGR Stock News - GuruFocus
Schrodinger (NASDAQ:SDGR) Price Target Lowered to $24.00 at TD Cowen - MarketBeat
Why Schrödinger Inc. stock is rated strong buyJuly 2025 Update & Free Real-Time Volume Trigger Notifications - ulpravda.ru
KeyBanc Maintains Overweight Rating for SDGR but Lowers Price Ta - GuruFocus
KeyCorp Issues Pessimistic Forecast for Schrodinger (NASDAQ:SDGR) Stock Price - MarketBeat
KeyBanc Maintains Schrodinger(SDGR.US) With Buy Rating, Cuts Target Price to $25 - 富途牛牛
UBS Initiates Coverage of Schrödinger (SDGR) with Neutral Recommendation - Nasdaq
SDGR: UBS Initiates Coverage with Neutral Rating | SDGR Stock Ne - GuruFocus
Wall Street Analysts Believe Schrodinger (SDGR) Could Rally 46.17%: Here's is How to Trade - Eastern Progress
Schrodinger stock initiated with Neutral rating at UBS on growth concerns - Investing.com
Schrodinger stock initiated with Neutral rating at UBS on growth concerns By Investing.com - Investing.com South Africa
Schrodinger, Inc. (SDGR) Stock Analysis: Unveiling a 47% Upside Potential Amidst Robust Revenue Growth - DirectorsTalk Interviews
Materials Informatics Market Size to Hit USD 736.71 Million by 2035 - GlobeNewswire Inc.
Here's Why Schrodinger (SDGR) Is a Great 'Buy the Bottom' Stock Now - MSN
Do Options Traders Know Something About Schrodinger Stock We Don't? - MSN
Schrodinger Inc Azioni (SDGR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.15%
2.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):